California biologics regulations.
Who may administer PRP, exosomes and stem cells in California, and which agencies to check.

Who may administer biologics in California?
Only licensed medical doctors (MDs) and doctors of osteopathic medicine (DOs) in California are permitted to administer stem cell therapies. Nurse practitioners and physician assistants may support in administering these treatments under direct supervision of a licensed physician.
Official sources
California compliance guide.
FDA Compliance
The U.S. Food and Drug Administration (FDA) regulates human cells, tissues, and cellular- and tissue-based products (HCT/Ps) under Section 361 of the Public Health Service Act and 21 CFR Part 1271. California providers must adhere to these federal guidelines, which detail requirements on sourcing, processing, and labeling of biologic materials, as well as how and when Investigational New Drug (IND) applications may be required.
California State Regulations
California enforces additional regulations through the California Department of Public Health (CDPH), with oversight on biologics that may involve stem cell and tissue-based therapies. Clinics are encouraged to review state-specific guidelines for stem cell treatments to ensure compliance with local standards, including patient safety and ethical administration practices.
Provider Qualifications
Only licensed medical doctors (MDs) and doctors of osteopathic medicine (DOs) in California are permitted to administer stem cell therapies. To learn more about licensure requirements, visit the Medical Board of California. Nurse practitioners and physician assistants may support in administering these treatments under direct supervision of a licensed physician.
Patient Informed Consent
Key Consent Elements:
California requires explicit patient consent that covers the experimental nature of biologics and potential risks. A compliant informed consent form should include:
- A detailed explanation of the procedure, including risks and benefits.
- Notification of the experimental or investigational nature of certain treatments, as biologics may not be FDA-approved for certain uses.
- Patient rights to discontinue treatment at any time without penalty.
Additional Compliance Steps
Pre-Treatment and Post-Treatment Protocols
Clinics should establish clear pre-treatment and post-treatment protocols, focusing on patient eligibility, follow-up visits, and outcome monitoring to ensure safety and regulatory compliance.
Standard Operating Procedures (SOPs)
Documented SOPs are essential for compliant administration, storage, and handling of biologic materials. They ensure consistency and adherence to both federal and state regulations.
Medical Liability Insurance
Clinics are encouraged to obtain adequate medical liability insurance that covers biologics and stem cell treatments to mitigate potential legal risks.
Marketing Compliance
Advertising for biologic treatments in California must adhere to FDA marketing regulations and cannot mislead patients regarding the efficacy or safety of treatments. Consult the FDA’s guidance on healthcare advertising to ensure all marketing efforts are compliant.
This guide is a general summary to help clinics understand compliance requirements for biologics in California. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.
California: common questions.
Who can administer stem cells, PRP and exosomes in California?
Are stem cell and exosome therapies FDA-approved in California?
Do I need an IRB-approved study to offer biologics in California?
How do I start offering biologics in California?
Practising in California? Start with the webinar.
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.